![COVID-19 vaccine booster dose needed to achieve Omicron-specific neutralisation in nursing home residents - eBioMedicine COVID-19 vaccine booster dose needed to achieve Omicron-specific neutralisation in nursing home residents - eBioMedicine](https://www.thelancet.com/cms/asset/be95fd01-303d-485d-806b-6d494baf486e/gr1.jpg)
COVID-19 vaccine booster dose needed to achieve Omicron-specific neutralisation in nursing home residents - eBioMedicine
![ACIP Evidence to Recommendations (EtR) for Use of Novavax COVID-19 Vaccine Booster Dose for adults ages 18 years and older under an Emergency Use Authorization | CDC ACIP Evidence to Recommendations (EtR) for Use of Novavax COVID-19 Vaccine Booster Dose for adults ages 18 years and older under an Emergency Use Authorization | CDC](https://www.cdc.gov/vaccines/acip/recs/grade/images/novavax-01-adult-schedule.png?_=39259)
ACIP Evidence to Recommendations (EtR) for Use of Novavax COVID-19 Vaccine Booster Dose for adults ages 18 years and older under an Emergency Use Authorization | CDC
![ACIP Evidence to Recommendations (EtR) for Use of Novavax COVID-19 Vaccine Booster Dose for adults ages 18 years and older under an Emergency Use Authorization | CDC ACIP Evidence to Recommendations (EtR) for Use of Novavax COVID-19 Vaccine Booster Dose for adults ages 18 years and older under an Emergency Use Authorization | CDC](https://www.cdc.gov/vaccines/acip/recs/grade/images/novavax-04-adult-schedule.png?_=39257)
ACIP Evidence to Recommendations (EtR) for Use of Novavax COVID-19 Vaccine Booster Dose for adults ages 18 years and older under an Emergency Use Authorization | CDC
![Novavax Expects Its Updated COVID-19 Vaccine Candidate to Work on Circulating Variants | Health News | U.S. News Novavax Expects Its Updated COVID-19 Vaccine Candidate to Work on Circulating Variants | Health News | U.S. News](https://www.usnews.com/object/image/00000188-91df-d70a-ab9b-b5dfc3d80000/ap22159814230246.jpg?update-time=1686075120969&size=responsive640)
Novavax Expects Its Updated COVID-19 Vaccine Candidate to Work on Circulating Variants | Health News | U.S. News
![ACIP Evidence to Recommendations (EtR) for Use of Novavax COVID-19 Vaccine Booster Dose for adults ages 18 years and older under an Emergency Use Authorization | CDC ACIP Evidence to Recommendations (EtR) for Use of Novavax COVID-19 Vaccine Booster Dose for adults ages 18 years and older under an Emergency Use Authorization | CDC](https://www.cdc.gov/vaccines/acip/recs/grade/images/novavax-02-adult-schedule.png?_=39252)
ACIP Evidence to Recommendations (EtR) for Use of Novavax COVID-19 Vaccine Booster Dose for adults ages 18 years and older under an Emergency Use Authorization | CDC
![Novavax vaccine for adolescents aged 12–17 years | Australian Government Department of Health and Aged Care Novavax vaccine for adolescents aged 12–17 years | Australian Government Department of Health and Aged Care](https://www.health.gov.au/sites/default/files/images/news/2022/08/novavax-vaccine-for-adolescents-aged-12-17-years_0.png)